AMS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
American Shared Hospital Services (AMS) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is currently in a bearish trend with weak financial performance, no significant positive catalysts, and no proprietary trading signals to support a buy decision.
The technical indicators show a bearish trend. The MACD is negative and expanding downward, the RSI indicates the stock is oversold at 1.592, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support levels are at 1.404 and 1.222, suggesting limited upward momentum.
The company announced a new partnership with Brown University Health and extended its lease with Orlando Health, which may provide some long-term operational stability.
AMS reported a 14.8% revenue decline in Q4 2025, missed earnings expectations, and posted a significant YoY drop in net income (-52.48%) and gross margin (-66.83%). These factors raise concerns about its financial health and investor confidence.
AMS's Q4 2025 financial performance was weak, with revenue dropping to $7.73 million (-14.79% YoY), net income falling to -$631,000 (-52.48% YoY), and EPS declining to -$0.09 (-55.00% YoY). Gross margin also dropped significantly to 11.72% (-66.83% YoY), reflecting declining profitability.
No recent analyst ratings or price target changes are available for AMS.
